@SamReganMD

Radiation Oncologist

Joined June 2020
  • Tweets14
  • Following124
  • Followers69
Sam Regan retweeted
ASTRO
@ASTRO_org2 Oct 2024
This new #advancesRO article from Regan et al was presented at #ASTRO24's Poster Q&A Session 08. Read their article "Microboost in Localized Prostate Cancer: Analysis of a Statewide Quality Consortium" here: tinyurl.com/reganam24
1
1
7
1,751
Our chief resident @SamReganMD taking the stage at #ASTRO24 to discuss @UMichRadOnc head and neck group's work exploring ctDNA in HPV+ head and neck cancer.
3
17
764
Samuel Regan, MD, and Benjamin Rosen, PhD, on De-escalating Radiotherapy for HPV-Related Oropharyngeal Cancer ascopost.com/videos/2024-mul… #hncsm #oropharyngealcancer #oncology #HNCS24 @UMich @SamReganMD

3
3
1,504
“We plan to continue to investigate the role of multimodal approaches for de-escalation of therapy for this patient population,” said Samuel Regan, MD. #hncsm #HNCS24 | @ASTRO_org @SamReganMD cancernetwork.com/view/chemo…

Chemoradiotherapy De-escalation Appears Feasible in HPV+ Oropharynx Cancer | CancerNetwork

The role of multimodal approaches such as FDG-PET imaging may require further investigation in patients with human papillomavirus–positive oropharyngeal cancer, according to Samuel Regan, MD.

cancernetwork.com
1
4
452
Our HNCa rad onc team's innovative work demonstrates enhanced patient quality of life with reduced chemo radiation in HPV+ oropharynx ca, all while ensuring tumor control! Kudos to @MierzwaMichelle @SamReganMD and team! @UMRogelCancer @umichmedicine michiganmedicine.org/health-…

Less chemoradiation is possible for some cancer patients

Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.

michiganmedicine.org
2
8
569
Congrats to two of our residents, Michael Dykstra and Sam Regan, for winning Conquer Cancer Merit Awards for their ASCO GU symposium abstracts! Both will be presenting work done with @MROQC1. conquer.org/news/conquer-can… @mdsquared44 @SamReganMD @UMichRadOnc @UMichMedSchool

Conquer Cancer Announces 2024 Genitourinary Cancers Symposium Merit Awards | Conquer Cancer, the...

ALEXANDRIA, Va. — Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of its 2024 Genitourinary Cancers Symposium Merit Awards.

conquer.org
1
3
14
782
#PROSPECT Diving into the acute patient-reported outcomes CRT⬆️diarrhea FOLFOX significantly higher rates of severe: 🔴Anxiety 🔴Depression 🔴Appetite 🔴Constipation 🔴Dysphagia 🔴Dyspnea 🔴Edema 🔴Fatigue 🔴Mucositis 🔴Nausea 🔴Vomiting 🔴Neuropathy 🤔 @PrajnanDasMD
Krishan Jethwa
@KrishanJethwa4 Jun 2023
🚨🚨🚨 PROSPECT Trial has landed! Congratulations to all investigators, @ALLIANCE_org, for this important trial! This study is important, will shape, and SHOULD alter practice for OPERATIVELY managed patients with favorable risk LA- rectal cancer. nejm.org/doi/full/10.1056/NE…

Preoperative Treatment of Locally Advanced Rectal Cancer | NEJM

Pelvic radiation plus sensitizing chemotherapy with a fluoropyrimidine (chemoradiotherapy) before surgery is standard care for locally advanced rectal cancer in North America. Whether neoadjuvant c...

nejm.org
11
53
2
125
63,580
Congrats to our newly matched residents! We are so happy to have you joining the @UMichRadOnc family! Can’t wait to work with you all!
2
4
60
2,380
Delighted to welcome our newly matched residents to the Michigan family! Congratulations! 🎉 @UMichRadOnc – at Ann Arbor, MI
1
7
3
71
6,864
Resident Tiki Party! 🏖️🏝️☀️🧉
1
3
19
1,255
Happy Halloween from University of Michigan Department of Radiation Oncology! The most caring animals you will find anywhere. 👻🎃🎃👻 Wishing everyone a safe Halloween! @UMRogelCancer @umichmedicine @ASTRO_org @ASCO
3
1
20
Delighted to present updated data from the PACIFIC trial in unresectable Stage III NSCLC @myESMO Durable benefit with durvalumab @4 years - almost 50% of patients alive - MS reached for the first time and is an unprecedented 47.5 months =major benefit for patients @MCRCnews
5
80
10
249
Today’s update on randomized trials investigating the life-prolonging value of SBRT for people with stage IV lung cancer. #ASCO20 #lcsm #radonc
4
32
5
103
Load more